Accretion Nutraveda IPO
smelistedAbout the company
Incorporated in 2021, Accretion Nutraveda Limited is a healthcare-focused company that deals in contract manufacturing of Ayurvedic and Nutraceutical products. The company is engaged in the manufacture of products in various dosage forms such as tablets, capsules, oral liquids, traditional Ayurvedic powders, medicated oils, and external preparations. The products cover a wide range of therapeutic categories like liver care, women's health, bone and joint support, respiratory health, digestive health, and brain function. The company has a leased factory at Sanand, Ahmedabad, with a total built-up area of around 10,763 sq. ft. spread over two floors. The company serves domestic as well as export markets in various countries like Sri Lanka, Singapore and the USA by offering a diverse range of dosage forms, leveraging both classical ayurvedic principles and modern nutraceutical science. The company runs its business through two main segments: Domestic sales/Merchant exports (on a loan license basis) and direct exports. The domestic and merchant export segment contributes over 96% of total revenue, while direct exports accounted for 3.38% in FY25. Geographically, Gujarat accounts for a major part of the revenue at 92.34% in FY25, followed by Maharashtra at 4.23%. Product-wise, external preparations accounted for 22.93% of the revenue in FY25, and the other contributors were tablets at 23.33%, capsules at 20.36%, oral powders at 19.69%, and oral liquids at 11.97%. Meanwhile, revenue contribution from the top 5 customers stands at 75.71%.
GMP trend (Grey Market Premium by date)
| Date | GMP (₹) | Est. Listing | Change |
|---|---|---|---|
| 29 Jan | ₹0 | ₹129 | 0 |
| 28 Jan | ₹0 | ₹129 | 0 |
| 27 Jan | ₹0 | ₹129 | 0 |
| 26 Jan | ₹0 | ₹129 | 0 |
| 25 Jan | ₹0 | ₹129 | 0 |
| 24 Jan | ₹0 | ₹129 | 0 |
| 23 Jan | ₹0 | ₹129 | 0 |
| 22 Jan | ₹0 | ₹129 | 0 |
Strengths
Risks
Financial performance (₹ Cr)
Subscription breakup (final, times)
IPO Roadmap / Timeline
IPO Opens
Completed28 Jan 2026Bidding starts for all investor categories
IPO Closes
Completed30 Jan 2026Last day to place your bid
Basis of Allotment
Completed02 Feb 2026Share allotment finalised
Refund Initiation
Completed03 Feb 2026Refunds credited for non-allottees
Credit to Demat
Completed03 Feb 2026Allotted shares credited to demat account
Listing on Exchange
Completed04 Feb 2026Shares list on NSE / BSE
Post-close dates are indicative as per SEBI T+3 listing framework and may change per registrar updates.
Lot size & minimum investment
| Investor Type | Min Lots | Min Shares | Min Amount | Max Lots | Max Amount | Notes |
|---|---|---|---|---|---|---|
| Retail / Individual | 1 | 1000 | ₹129,000 | 1 | ₹129,000 | 1 lot only |
| HNI | 2 | 2000 | ₹258,000 | 2 | ₹258,000 | Min 2 lots |
Shares reserved per category & allotment probability
| Category | Reservation | Shares Offered | Amount (₹ Cr) | Shares Bid | Subscribed | Allotment % |
|---|---|---|---|---|---|---|
| QIB | 50% | 996,016 | 12.5 | 0 | 0.00x | 100% |
| NII | 15% | 298,805 | 3.75 | 0 | 0.00x | 100% |
| Retail | 35% | 697,211 | 8.75 | 0 | 0.00x | 100% |
Retail is a lottery-based allotment when oversubscribed; QIB/NII get pro-rata. Probability ≈ 1 / subscription times (100% if under-subscribed).
